Literature DB >> 15086548

Homozygous splice site mutations in PKP1 result in loss of epidermal plakophilin 1 expression and underlie ectodermal dysplasia/skin fragility syndrome in two consanguineous families.

Eli Sprecher1, Vered Molho-Pessach, Arieh Ingber, Efraim Sagi, Margarita Indelman, Reuven Bergman.   

Abstract

During the last years, a growing number of inherited skin disorders have been recognized to be caused by abnormal function of desmosomal proteins. In the present study, we describe the first female individuals affected with the ectodermal dysplasia/skin fragility syndrome (MIM604536), a rare autosomal recessive disease due to mutations in the PKP1 gene encoding plakophilin 1, a critical component of desmosomal plaque. One patient was shown to carry a homozygous splice site mutation in intron 4. The second patient displayed a homozygous recurrent mutation affecting the acceptor splice site of intron 1. Both mutations were associated with intraepidermal separation, widening of intercellular spaces, and abnormal desmosome ultrastructure, and were found to result in the absence of immunoreactive plakophilin 1 in the epidermis of the affected individuals. These two cases emphasize the role of molecular genetics in the assessment of congenital blistering in newborns and illustrate the importance of proper desmosomal activity for normal epidermis development and function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086548     DOI: 10.1111/j.0022-202X.2004.22335.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  A plakophilin-1 gene mutation in an egyptian family with ectodermal dysplasia-skin fragility syndrome.

Authors:  Ebtesam M Abdalla; Cristina Has
Journal:  Mol Syndromol       Date:  2014-11-28

Review 2.  Gene expression in stress urinary incontinence: a systematic review.

Authors:  Ilaha Isali; Amr Mahran; Ahmad O Khalifa; David Sheyn; Mandy Neudecker; Arshna Qureshi; Britt Conroy; Fredrick R Schumacher; Adonis K Hijaz; Sherif A El-Nashar
Journal:  Int Urogynecol J       Date:  2019-07-16       Impact factor: 2.894

3.  The desmosomal plaque proteins of the plakophilin family.

Authors:  Steffen Neuber; Mario Mühmer; Denise Wratten; Peter J Koch; Roland Moll; Ansgar Schmidt
Journal:  Dermatol Res Pract       Date:  2010-04-21

Review 4.  Progress in heritable skin diseases: translational implications of mutation analysis and prospects of molecular therapies*.

Authors:  Jouni Uitto
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437

5.  Cancer biomarker discovery: the entropic hallmark.

Authors:  Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

6.  Phosphorylation of Pkp1 by RIPK4 regulates epidermal differentiation and skin tumorigenesis.

Authors:  Philbert Lee; Shangwen Jiang; Yuanyuan Li; Jiping Yue; Xuewen Gou; Shao-Yu Chen; Yingming Zhao; Markus Schober; Minjia Tan; Xiaoyang Wu
Journal:  EMBO J       Date:  2017-05-15       Impact factor: 11.598

7.  Deficient plakophilin-1 expression due to a mutation in PKP1 causes ectodermal dysplasia-skin fragility syndrome in Chesapeake Bay retriever dogs.

Authors:  Thierry Olivry; Keith E Linder; Ping Wang; Petra Bizikova; Joseph A Bernstein; Stanley M Dunston; Judy S Paps; Margret L Casal
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

8.  Plakophilin-3 is required for late embryonic amphibian development, exhibiting roles in ectodermal and neural tissues.

Authors:  William A Munoz; Malgorzata Kloc; Kyucheol Cho; Moonsup Lee; Ilse Hofmann; Amy Sater; Kris Vleminckx; Pierre D McCrea
Journal:  PLoS One       Date:  2012-04-05       Impact factor: 3.240

9.  Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation.

Authors:  Katja S Grossmann; Christine Grund; Joerg Huelsken; Martin Behrend; Bettina Erdmann; Werner W Franke; Walter Birchmeier
Journal:  J Cell Biol       Date:  2004-10-11       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.